Bruker BRKR Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Bsi Biospin | $878.8M-3.0% | $905.7M— | —— | —— | |
| Bsi Calid | $1.21B+10.7% | $1.09B— | —— | —— | |
| Bsi Nano | $1.08B-1.3% | $1.1B— | —— | $787M+12.8% | |
| Energy And Supercon Technologies | $270.9M-4.3% | $283M+0.8% | $280.7M+18.4% | $237.1M+5.9% | |
| Cost Of Segment Revenue by Business | |||||
| Bsi Biospin | $465.9M+6.4% | $437.7M+16.8% | $374.8M+16.9% | $320.6M— | |
| Bsi Calid | $525.2M+12.8% | $465.4M+18.4% | $393.2M+18.9% | $330.8M— | |
| Bsi Nano | $524M+1.0% | $518.9M+18.4% | $438.2M+17.4% | $373.2M— | |
| Energy And Supercon Technologies | $218.5M-1.8% | $222.5M-1.5% | $225.9M+21.3% | $186.2M— | |
| Operating Income by Business | |||||
| Bsi Biospin | $156.5M-27.7% | $216.6M+2.6% | $211.2M— | —— | |
| Bsi Calid | $262.5M+6.6% | $246.2M+6.1% | $232.1M+7.3% | $216.4M-4.8% | |
| Bsi Nano | $101.1M-18.3% | $123.7M-21.9% | $158.4M+14.7% | $138.1M+88.1% | |
| Energy And Supercon Technologies | $26.7M-23.9% | $35.1M+8.0% | $32.5M+6.9% | $30.4M+36.9% | |
| Selling General And Administrative Expense by Business | |||||
| Bsi Biospin | $162.7M+2.4% | $158.9M+18.0% | $134.7M+11.3% | $121M— | |
| Bsi Calid | $302.8M+12.1% | $270.2M+13.2% | $238.7M+19.4% | $200M— | |
| Bsi Nano | $284M-2.4% | $290.9M+27.6% | $228M+23.1% | $185.2M— | |
| Energy And Supercon Technologies | $22.3M+3.7% | $21.5M+11.4% | $19.3M+7.2% | $18M— | |
| Total Assets by Business | |||||
| BSI Bio Spin CALIDNANO And Corporate | $24.34B— | —— | —— | —— | |
| Energy And Supercon Technologies | $779.8M+3.0% | $757.4M+9.5% | $691.6M+78.2% | $388.1M+1.1% | |
| Segment Expenditure Addition To Long Lived Assets by Business | |||||
| Bsi Biospin | $11.4M-50.0% | $22.8M-4.6% | $23.9M+64.8% | $14.5M-60.4% | |
| Bsi Calid | $25.3M-25.6% | $34M+8.3% | $31.4M-7.4% | $33.9M+37.2% | |
| Bsi Nano | $36.5M+88.1% | $19.4M+39.6% | $13.9M-31.2% | $20.2M+20.2% | |
| Corporate | $16M+9.6% | $14.6M+43.1% | $10.2M+12.1% | $9.1M+93.6% | |
| Energy And Supercon Technologies | $13.8M-43.4% | $24.4M-11.3% | $27.5M-46.6% | $51.5M+460% | |
| Research And Development Expense by Business | |||||
| Bsi Biospin | $93.7M+1.3% | $92.5M+18.9% | $77.8M+15.4% | $67.4M— | |
| Bsi Calid | $119.7M+7.2% | $111.7M+15.9% | $96.4M+28.5% | $75M— | |
| Bsi Nano | $175.2M+6.3% | $164.8M+40.5% | $117.3M+29.6% | $90.5M— | |
| Energy And Supercon Technologies | $3.4M-12.8% | $3.9M+30.0% | $3M+20.0% | $2.5M— | |
| Restructuring Charges by Business | |||||
| Bsi Biospin | $9M+463% | $1.6M-5.9% | $1.7M+30.8% | $1.3M— | |
| Bsi Calid | $19.7M+579% | $2.9M+52.6% | $1.9M+533% | $300K— | |
| Bsi Nano | $13M+27.5% | $10.2M-29.2% | $14.4M+7,100% | $200K— | |
| Corporate | $3.2M+540% | $500K-37.5% | $800K-61.9% | $2.1M— | |
| D&A by Business | |||||
| Bsi Biospin | $43.2M+5.4% | $41M+59.5% | $25.7M+13.7% | $22.6M+6.1% | |
| Bsi Calid | $92.3M+37.6% | $67.1M+129% | $29.3M+41.5% | $20.7M+4.5% | |
| Bsi Nano | $67.2M+8.9% | $61.7M+28.5% | $48M+34.8% | $35.6M-4.8% | |
| Corporate | $8.2M+49.1% | $5.5M+17.0% | $4.7M+20.5% | $3.9M-9.3% | |
| Energy And Supercon Technologies | $9.4M+11.9% | $8.4M+16.7% | $7.2M+20.0% | $6M-4.8% | |
| Revenue by Product | |||||
| Product And Service Other | $670.1M+10.4% | $607.2M+19.8% | $506.9M+59.6% | $317.6M+4,192% | |
| Product | $2.77B+0.3% | $2.76B+12.3% | $2.46B+16.5% | $2.11B+4.6% | |
| Cost Of Revenue by Product | |||||
| License | $9.9M-2.0% | $10.1M+34.7% | $7.5M+17.2% | $6.4M+10.3% | |
| Product And Service Other | $372.3M+5.6% | $352.4M+23.2% | $286M+57.7% | $181.4M+25,814% | |
| Product | $1.49B+8.9% | $1.36B+17.1% | $1.17B+18.4% | $984M+0.5% | |
| Revenue by Geography | |||||
| Asia Pacific Excluding China | $552.6M+6.6% | $518.5M+12.5% | $460.9M— | —— | |
| CN | $475.8M+1.0% | $471.2M-10.8% | $528.1M+33.2% | $396.5M+10.9% | |
| DE | $297M-4.4% | $310.7M+10.4% | $281.5M+13.8% | $247.4M-5.8% | |
| Europe Excluding Germany | $950.2M+8.8% | $873M+24.8% | $699.7M— | —— | |
| Other Country | $269.6M+5.9% | $254.5M+17.5% | $216.6M+13.8% | $190.4M+13.9% | |
| US | $891.3M-5.0% | $938.5M+20.7% | $777.7M+11.7% | $696.1M+15.8% | |
| Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Ratee by Geography | |||||
| CH | 1%-0.4pp | 1.4%-1.0pp | 2.4%+2.0pp | 0.4%+0.3pp | |
| DE | 3.1%-0.5pp | 3.6%-0.3pp | 3.9%+3.1pp | 0.8%+0.3pp | |
| FR | 3.3%+0.1pp | 3.2%-0.6pp | 3.8%+2.8pp | 1%+0.4pp | |
| IT | 3.4%-0.2pp | 3.6%— | —— | —— | |
| JP | 1.4%+0.3pp | 1.1%+0.2pp | 0.9%+0.5pp | 0.4%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bruker break its business down?
- Bruker (BRKR) reports revenue by business across 4 parts — Bsi Biospin, Bsi Calid, Bsi Nano and Energy And Supercon Technologies. Each is extracted from the segment footnotes and tracked over time.
- Where does Bruker's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bruker's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
